Bayer Aktiengesellschaft

One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin

WHIPPANY, N.J., July 28, 2026--One A Day®, the multivitamin and supplement brand from Bayer, today announced a new formula for One A Day® Women's Multi Gummy, which now delivers 1,000 mcg of Biotin per serving (serving size is two gummies).

Yahoo Finance · 28/07/2026 · lire l'article ↗

Crop seed producer Bayer plans layoffs in Hawaii

One of Hawaii’s major crop seed research and development companies plans to lay off around 76 employees. A subsidiary of Germany-­based pharmaceutical, biotechnology and agriculture company Bayer AG announced the planned layoffs in a notice filed with the state Department of Labor and Industrial Relations. Bayer, which has seed operations on Oahu, Maui and Molokai, said it is making ...

Yahoo Finance · 24/07/2026 · lire l'article ↗

New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

LEVERKUSEN, Germany, July 23, 2026--Self-care, when effectively integrated into health systems, can improve health outcomes, expand access to healthcare services and reduce pressure on overstretched health systems, according to new research by Economist Enterprise. The research, supported by Bayer and published in a report titled "Making self-care work: integrating self-care into health systems", cites existing evidence estimating that self-care practices can deliver approximately US$ 179 billio

Yahoo Finance · 23/07/2026 · lire l'article ↗

Bayer (XTRA:BAYN) Stock Sees Fair Value Lift As Analysts Reassess Litigation Risk

The updated analyst work on Bayer centres on a higher fair value estimate, with the central valuation mark lifted from €34.97 to €54.92 per share. This shift is closely linked to recent research that weighs contained but ongoing litigation risk, execution on portfolio moves, and fresh views on Bayer’s pipeline, which together shape where price targets now cluster. As you read on, you will see how these valuation changes fit into the evolving analyst narrative and what to watch in order to...

Yahoo Finance · 23/07/2026 · lire l'article ↗

Bayer (XTRA:BAYN) Stock Gets Two New Research Deals In Cancer And Heart Health

Bayer announced two new collaborations, one with Kairos Pharma on a prostate cancer therapy and another with Henry Ford Health on wider research across several diseases. The Kairos Pharma partnership focuses on combination treatments for metastatic prostate cancer. The alliance with Henry Ford Health covers cardiovascular, oncology, and women’s health research using advanced data and clinical technologies. Bayer, traded under XTRA:BAYN, is adding these research deals alongside a share price...

Yahoo Finance · 22/07/2026 · lire l'article ↗

Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer

LOS ANGELES, July 22, 2026--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced a strategic collaboration with Bayer to evaluate Kairos Pharma’s lead antibody ENV-105 (carotuximab), a first-in-class CD105/BMP signaling inhibitor, in combination with Bayer’s XOFIGO (radium-223 dichloride) in metastatic castration-resistant prostate cancer (mCRPC) involving bone.

Yahoo Finance · 22/07/2026 · lire l'article ↗